Thalassemia

last authored:
last reviewed:

 

 

 

Introduction

Thalassemias are a heterogenous group of genetic disorders of hemoglobin synthesis. They are characterized by a reduced rate of synthesis of one or more alpha/beta globin chains.

 

Thalassemias are the most common inherited abnormalities of hemoglobin. Beta thalassemia is most common in Mediterranian populations, while alpha thalassemia is most common in southeast Asian populations.

Not structural abnormality of hemoglobin, but rather disruption of amounts of hemoglobins.

There is important stochiometry between alpha and beta globin.

Thalassemias can be deficiencies in alpha or beta, leading to abnormal tetramers.

 

 

 

The Case of...

a simple case introducing clincial presentation and calling for a differential diagnosis to get students thinking.

return to top

 

 

 

Causes and Risk Factors

Beta thalassemia

typically presents when fetal hemoglobin transitions to

 

Alpha thalassemia:

Can present in newborn period

return to top

 

 

 

Pathophysiology

There are two beta genes and four alpha genes that code for hemoglobin production, with is composed of two copies of each protein.

 

Alpha thalassemia is usually an autosomal recessive disease. There are two alpha globin genes on chromosome 16, with four loci total. Disease depends on the number of loci affected:

Decreased α chain production leads to decreased hemoglobin synthesis and also β chain tetramers. As these are fairly soluble (though abnormal), there is decreased hemolysis with alpha thalassemia.

 

Beta thalassemia comes about due to mutations in the beta globin gene. It also is an autosomal recessive disease. β0 is a nonsense mutation in the coding region, leading to no gene expression. A homozygous β0 leads to thalassemia major.

β+ is a mutation leading to altered mRNA splicing and decreased gene expression.

Decreased β chain production leads to decreased hemoglobin synthesis and also α chain tetramers. These are poorly soluble, leading to hemolysis. An intense bone marrow expansion leads to skeletal abnormalities. Hemolysis leads to massive liver and splenic enlargement.

return to top

 

 

 

Signs and Symptoms

  • history
  • physical exam

History

Beta-thalassemia often presents at ages 3-6 months, as HbF is replaced by HbA. It can cause severe anemia, jaundice, and significant splenomegaly.

 

Physical Exam

 

return to top

 

 

 

Investigations

  • lab investigations
  • diagnostic imaging

Lab Investigations

A complete blood count will show

  • anemia
  • microcytosis
  • hypochromia

A peripheral blood smear will show:

  • increased reticulocytes
  • basophilic stippling
  • target cells
  • Howell-Jolly bodies post-splenectomy

Hemoglobin electrophoresis can reveal

  • HbA 0-10%, with HbF 90-100%

DNA analysis may be carried out for alpha gene mutations.

Diagnostic Imaging

Skeletal abnormalities and pathological fractures can be seen with beta-thalassemia.

 

return to top

 

 

 

Differential Diagnosis

 

return to top

 

 

 

Treatments

Treat with frequent transfusions and iron chelations.

A bone marrow transplant may also be considered.

 

return to top

 

 

 

Consequences and Course

Cholelithiasis can result from increased hemoglobin catabolism.

Hemochromatosis can follow numerous transfusions.

return to top

 

 

 

Resources and References

 

return to top

 

 

Topic Development

authors:

reviewers:

 

return to top